Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 22/8/2017
SIETES contiene 91973 citas

 
 
 1 a 20 de 568 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Oldenburg J, Mahlangu JN, Kim B, Schmitt C, Callaghan MU, Young J, Santagostino E, Kruse-Jarres R, Negrier C, Kessler C, Valente N, Asikanius E, Levy GG, Windyga J, Shima M. Emicizumab prophylaxis in hemophilia A with inhibitors. N Engl J Med 2017:1. [Ref.ID 101908]
2. Cita con resumen
Waljee AK, Rogers MAM, Lin P, Singal AG, Stein JD, Marks RM, Ayanian JZ, Nallamothu BK. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ 2017;357:j1415. [Ref.ID 101633]
3. Cita con resumen
Weitz JI, Lensing AWA, Prins MH, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Freitas MCS, Holberg G, Kakkar AK, Haskell L, van Bellen B, Pap AF, Berkowitz SD, Verhamme P, Wells PS, Prandoni P, for the EINSTEIN CHOICE Investigators. Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N Engl J Med 2017;376:1211-22. [Ref.ID 101509]
4.Enlace a cita original Cita con resumen
Martinez C, Suissa S, McGill J, Rietbrock S, Katholing A, Freedman B, Cohen AT, Handelsman DJ. Testosterone treatment and risk of venous thromboembolism: population based case-control study. BMJ 2016;355:i5968. [Ref.ID 101016]
5.Tiene citas relacionadas Cita con resumen
Righini M, Galanaud J-P, Guenneguez H, Brisot D, Diard A, Faisse P, Barrellier M-T, Hamel-Desnos C, Jurus C, Pichot O, Martin M, Mazzolai L, Choquenet C, Accassat S, Robert-Ebadi H, Carrier M, Le Gal G, Mermillod B, Laroche J-P, Bounameaux H, Perrier A, Kahn SR, Quere I. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial. The Lancet Haematology 2016:noviembre. [Ref.ID 100906]
6.Enlace a cita originalTiene citas relacionadas Cita con resumen
Schellong SM. Low risk is not enough: the dilemma of calf vein thrombosis. The Lancet Haematology 2016:7 de noviembre. [Ref.ID 100905]
7. Cita con resumen
Nielen JTH, Dagnelie PC, Emans PJ, Veldhorst-Janssen N, Lalmohamed A, Van Staa T-P, Boonen AERCH, van den Bemt BJF, de Vries F. Safety and efficacy of new oral anticoagulants and low-molecular-weight heparins compared with aspirin in patients undergoing total knee and hip replacements. Pharmacoepidemiol Drug Saf 2016;25:1245-52. [Ref.ID 100896]
8. Cita con resumen
Gargiulo G, Windecker S, da Costa BR, Feres F, Hong M-K, Gilard M, Kim H-S, Colombo A, Bhatt DL, Kim B-K, Morice M-C, Park KW, Chieffo A, Palmerini T, Stone GW, Valgimigli M. Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials. BMJ 2016;355:i5483. [Ref.ID 100878]
9. Cita con resumen
Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, Hernandez AF, Gibson CM, for the APEX Investigators. Extended thromboprophylaxis with betrixaban in acutely ill medical patients. N Engl J Med 2016;375:534-44. [Ref.ID 100706]
10. Cita con resumen
Utter GH, Dhillon TS, Salcedo ES, Shouldice DJ, Reynolds CL, Humphries MD, White RH. Therapeutic anticoagulation for isolated calf deep vein thrombosis. JAMA Surgery 2016:20 de julio. [Ref.ID 100578]
11. Cita con resumen
Peyvandi F, Scully M, Kremer HJA, Cataland S, Knöbl P, Wu H, Antoni A, Westwood JP, Mansouri TM, Jilma B, Callewaert F, Ulrichts H, Duby C, Tersago D, TITAN Investigators. Caplacizumab for acquired thrombotic thrombocytopenic purpura. N Engl J Med 2016;374:511-22. [Ref.ID 100129]
12. Cita con resumen
Cassese S, Byrne RA, Ndrepepa G, Kufner S, Wiebe J, Repp J, Schunkert H, Fusaro M, Kimura T, Kastrati A. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials. Lancet 2016;387:537-44. [Ref.ID 100119]
13. Cita con resumen
Young K. Who might benefit from long-term DAPT? Risk score may help . Journal Watch 2015:1. [Ref.ID 99636]
14. Cita con resumen
Stam-Slob MC, Lambalk CB, van de Ree MA. Contraceptive and hormonal treatment options for women with history of venous thromboembolism. BMJ 2015;351:h4847. [Ref.ID 99595]
15.Tiene citas relacionadas Cita con resumen
Eerenberg ES, Middeldorp S, Levi M, Lensing AW, Büller HR. Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists. J Thromb Haemost 2015;13:1590-6. [Ref.ID 99547]
16. Cita con resumen
Giustino G, Baber U, Sartori S, Mehran M, Mastoris I, Kini AS, Sharma SK, Pocock SJ, Dangas GD. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials.. Journal of The Americal College of Cardiology 2015;65:1298-310. [Ref.ID 99446]
17. Cita con resumen
Pandit A, Giri S, Hakim FA, Fortiun FD. Shorter (=6 months) versus longer (=12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials. Catheterization and Cardiovascular Interventions 2015;85:34-40. [Ref.ID 99445]
18. Cita con resumen
Anónimo. Injections épidurales de corticoïde: troubles neurologiques graves. Prescrire 2015;35:429. [Ref.ID 99427]
19.Tiene citas relacionadas Cita con resumen
Dear JW, Antoine DJ, Park BK. Where are we now with paracetamol?. BMJ 2015;351:h3705. [Ref.ID 99251]
20. Cita con resumen
Couturaud F, Sanchez O, Pernod G, Mismetti P, Jego P, Duhamel E, Provost K, Bal dit Sollier C, Presles E, Castellant P, Parent F, Salaun P-Y, Bressollette L, Nonent M, Lorillon P, Girard P, Lacut K, Guégan M, Bosson J-L, Laporte S, Leroyer C, Décousus H, Meyer G, Mottier D, for the PADIS-PE Investigators. Six months vs extended oral anticoagulation after a first episode of pulmonary embolism: the PADIS-PE randomized clinical trial. JAMA 2015;314:31-40. [Ref.ID 99242]
Seleccionar todas
 
 1 a 20 de 568 siguiente >>